Schematic ion channel with potential sites for drug modulation of function and the associated contributions to 1, binding in the pore (active site) to block ion movement, which may be small, maybe zero; 2, binding to allosteric sites formed by the protein, which will contribute to (e.g., Jackson, 1989); 3, binding to allosteric sites formed by the protein plus bilayer lipids, which will contribute both and (e.g., Obi and Natesan, 2022), as well as the so-called residual exposure contribution due to imperfects hydrophobic matching between membrane proteins and their host bilayer (Mondal et al., 2011); 4, non-specific binding/enrichment at the protein/bilayer boundary, which will contribute to and maybe also and 5, partitioning into the bilayer/solution interface to alter bulk bilayer properties, which will contribute to After Andersen, 2008 and Herold et al., 2014; see also Urban, 2002.